SCHEMBL4171352

SCHEMBL4171352

BrCc1cccc(-c2cccs2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.63
LTA4H P09960 1/20 0.52
CYP17A1 P05093 1/20 0.46
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
FFAR1 O14842 1/20 0.46
KCNH2 Q12809 1/20 0.46
CYP2E1 P05181 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2A6 P11509 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2B6 P20813 1/20 0.43
PSMB5 P28074 2/20 0.43
CETP P11597 1/20 0.43
HDAC1 Q13547 1/20 0.41
FFAR4 Q5NUL3 1/20 0.39
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
FYN P06241 1/20 0.39
ERN1 O75460 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1437852 0.82 LTA4H (0.68) PRMT6LTA4HCYP17A1CYP11B1CYP11B2
SCHEMBL21408614 0.82 PRMT6 (0.64) PRMT6LTA4HCYP17A1CYP11B1CYP11B2
SCHEMBL477487 0.81 PRMT6 (0.63) PRMT6LTA4HCYP17A1CYP11B1CYP11B2
SCHEMBL158066 0.81 PRMT6 (0.68) PRMT6LTA4HCYP17A1CYP11B1CYP11B2
SCHEMBL111078 0.81 LTA4H (0.72) PRMT6LTA4HCYP17A1CYP11B1CYP11B2
SCHEMBL7499623 0.81 PRMT6 (0.63) PRMT6LTA4HCYP17A1CYP11B1CYP11B2
SCHEMBL1334921 0.80 KCNH2 (0.59) PRMT6LTA4HCYP17A1CYP11B1CYP11B2
SCHEMBL11482011 0.79 PRMT6 (0.59) PRMT6LTA4HCYP17A1CYP11B1CYP11B2
SCHEMBL6601600 0.79 PRMT6 (0.64) PRMT6LTA4HCYP17A1CYP11B1CYP11B2
SCHEMBL5018750 0.77 PRMT6 (0.62) PRMT6LTA4HCYP17A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968368-A Amide compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2025-05-09 CN disclosed
CN-117402156-A Amide compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2024-01-16 CN disclosed
US-20090105292-A9 Glucocorticoid Receptor Modulator Compounds and Methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-04-23 US disclosed
US-20070281959-A1 Glucocorticoid receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED (US) 2007-12-06 US disclosed
EP-1718653-A1 GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY Ligand Pharmaceuticals Inc. (US) 2006-11-08 EP disclosed
WO-2005082909-A1 GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY LIGAND PHARMACEUTICALS INCORPORATED (US) 2005-09-09 WO disclosed
US-4426524-A Heterocyclic substituted benzyl alcohol, insecticidal ester derivatives, and intermediates FMC CORPORATION (US) 1984-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105292-A9 Glucocorticoid Receptor Modulator Compounds and Methods NR3C1, NR3C2, MC2R PRMT6 2078/4885LTA4H 399/4885CYP17A1 67/4885
US-20070281959-A1 Glucocorticoid receptor modulator compounds and methods NR3C1, NR3C2, MC2R PRMT6 2078/4885LTA4H 399/4885CYP17A1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.